ValoTec stems from Ecole Normale Supérieure de Paris-Salcay (SATIE laboratory) one of the best research centers in France, and accompanies it’s clients since 2005 in their R&D projects and production projects

ValoTec is specialized in the following domains :

Active innovative devices (all industries)
Class IIa IIb and III medical devices (MedTech)
Implantable devices
Patient treatment devices
Diagnostic devices
In 2019, ValoTec launched MELLIsim , it’s subsidiary dedicated to a research program on diabetes

In 2020, ValoTec acquired Futurs Health Products, a company specialized in innovation management, clinical, regulatory and medico-economic strategy for medical devices

ValoTec is a Member of Medicen, Systematic and Biowin and is labeled as « Société de Recherche Sous Contrat » (SRC) by BPI France (French bank of Investment)

Since 2012, ValoTec is certified ISO 9001 (technical devices) and ISO 13485 (medical devices) for consultancy, development, manufacturing/distribution

ValoTec is also approved for CIR & CII tax credits for research in France.

ValoTec

Org chart

Teams

Offices